Applied Therapeutics, Inc. Operating Income
Applied Therapeutics, Inc. reported Operating Income of -$16.76 million for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2025-11-13
- Applied Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$16.76M.
- Applied Therapeutics, Inc. operating income (loss) for the quarter ending 2025-06-30 was -$23.10M.
- Applied Therapeutics, Inc. operating income (loss) for the quarter ending 2025-03-31 was -$25.52M.
- Applied Therapeutics, Inc. operating income (loss) for the quarter ending 2024-12-31 was -$33.02M.
- Applied Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$104.30M.
- Applied Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$64.53M.
- Applied Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$82.95M.
- Applied Therapeutics, Inc. operating income (loss) for fiscal 2021 was -$105.62M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$16.76M 10-Q · filed 2025-11-13 | -$39.86M derived: sum of 2 quarters · filed 2025-11-13 | -$65.38M 10-Q · filed 2025-11-13 | -$98.40M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | -$23.10M 10-Q · filed 2025-08-13 | -$48.62M 10-Q · filed 2025-08-13 | -$81.64M derived: sum of 3 quarters · filed 2025-08-13 | -$111.39M derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | -$25.52M 10-Q · filed 2025-05-14 | -$58.55M derived: sum of 2 quarters · filed 2025-05-14 | -$88.29M derived: sum of 3 quarters · filed 2025-11-13 | -$108.73M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | -$33.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$62.77M derived: sum of 2 quarters · filed 2025-11-13 | -$83.20M derived: sum of 3 quarters · filed 2025-11-13 | -$104.30M 10-K · filed 2025-04-15 |
| 2024-09-30 | -$29.74M 10-Q · filed 2025-11-13 | -$50.18M derived: sum of 2 quarters · filed 2025-11-13 | -$71.28M 10-Q · filed 2025-11-13 | -$92.28M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | -$20.44M 10-Q · filed 2025-08-13 | -$41.53M 10-Q · filed 2025-08-13 | -$62.54M derived: sum of 3 quarters · filed 2025-08-13 | -$78.04M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$21.09M 10-Q · filed 2024-05-09 | -$42.10M derived: sum of 2 quarters · filed 2025-04-15 | -$57.60M derived: sum of 3 quarters · filed 2025-04-15 | -$74.77M derived: sum of 4 quarters · filed 2025-04-15 |
| 2023-12-31 | -$21.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | -$36.50M derived: sum of 2 quarters · filed 2025-04-15 | -$53.68M derived: sum of 3 quarters · filed 2025-04-15 | -$64.53M 10-K · filed 2025-04-15 |
| 2023-09-30 | -$15.49M 10-Q · filed 2024-11-07 | -$32.67M derived: sum of 2 quarters · filed 2024-11-07 | -$43.53M 10-Q · filed 2024-11-07 | -$62.50M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$17.18M 10-Q · filed 2024-08-07 | -$28.03M 10-Q · filed 2024-08-07 | -$47.01M derived: sum of 3 quarters · filed 2024-08-07 | -$66.36M derived: sum of 4 quarters · filed 2024-08-07 |
| 2023-03-31 | -$10.86M 10-Q · filed 2024-05-09 | -$29.83M derived: sum of 2 quarters · filed 2024-05-09 | -$49.19M derived: sum of 3 quarters · filed 2024-05-09 | -$70.71M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$18.97M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-06 | -$38.33M derived: sum of 2 quarters · filed 2024-03-06 | -$59.85M derived: sum of 3 quarters · filed 2024-03-06 | -$82.95M 10-K · filed 2024-03-06 |
| 2022-09-30 | -$19.36M 10-Q · filed 2023-11-09 | -$40.88M derived: sum of 2 quarters · filed 2023-11-09 | -$63.98M 10-Q · filed 2023-11-09 | -$91.09M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$21.52M 10-Q · filed 2023-08-10 | -$44.62M 10-Q · filed 2023-08-10 | -$71.74M derived: sum of 3 quarters · filed 2023-08-10 | -$100.17M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$23.10M 10-Q · filed 2023-05-11 | -$50.22M derived: sum of 2 quarters · filed 2023-05-11 | -$78.64M derived: sum of 3 quarters · filed 2023-05-11 | -$104.52M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$27.11M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | -$55.54M derived: sum of 2 quarters · filed 2023-03-23 | -$81.42M derived: sum of 3 quarters · filed 2023-03-23 | -$105.62M 10-K · filed 2023-03-23 |
| 2021-09-30 | -$28.43M 10-Q · filed 2022-11-09 | -$54.30M derived: sum of 2 quarters · filed 2022-11-09 | -$78.50M 10-Q · filed 2022-11-09 | -$102.25M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | -$25.88M 10-Q · filed 2022-08-12 | -$50.07M 10-Q · filed 2022-08-12 | -$73.82M derived: sum of 3 quarters · filed 2022-08-12 | -$103.79M derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | -$24.20M 10-Q · filed 2022-05-12 | -$47.95M derived: sum of 2 quarters · filed 2022-05-12 | -$77.91M derived: sum of 3 quarters · filed 2022-05-12 | -$106.19M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$23.75M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$53.71M derived: sum of 2 quarters · filed 2022-03-10 | -$81.99M derived: sum of 3 quarters · filed 2022-03-10 | -$94.47M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$29.96M 10-Q · filed 2021-11-12 | -$58.24M derived: sum of 2 quarters · filed 2021-11-12 | -$70.72M 10-Q · filed 2021-11-12 | -$88.38M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$28.28M 10-Q · filed 2021-08-12 | -$40.75M 10-Q · filed 2021-08-12 | -$58.42M derived: sum of 3 quarters · filed 2021-08-12 | -$69.16M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$12.47M 10-Q · filed 2021-05-11 | -$30.14M derived: sum of 2 quarters · filed 2021-05-11 | -$40.88M derived: sum of 3 quarters · filed 2021-05-11 | -$49.32M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$17.67M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | -$28.42M derived: sum of 2 quarters · filed 2021-03-18 | -$36.85M derived: sum of 3 quarters · filed 2021-03-18 | -$45.58M 10-K · filed 2021-03-18 |
| 2019-09-30 | -$10.75M 10-Q · filed 2020-11-12 | -$19.18M derived: sum of 2 quarters · filed 2020-11-12 | -$27.91M 10-Q · filed 2020-11-12 | -$33.90M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$8.44M 10-Q · filed 2020-08-11 | -$17.16M 10-Q · filed 2020-08-11 | -$23.16M derived: sum of 3 quarters · filed 2020-08-11 | -$26.48M derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | -$8.73M 10-Q · filed 2020-05-11 | -$14.72M derived: sum of 2 quarters · filed 2020-05-11 | -$18.04M derived: sum of 3 quarters · filed 2020-05-11 | -$20.38M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$5.99M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$9.31M derived: sum of 2 quarters · filed 2020-03-13 | -$11.65M derived: sum of 3 quarters · filed 2020-03-13 | -$13.52M 10-K · filed 2020-03-13 |
| 2018-09-30 | -$3.32M 10-Q · filed 2019-11-13 | -$5.66M derived: sum of 2 quarters · filed 2019-11-13 | -$7.53M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$2.34M 10-Q · filed 2019-08-12 | -$4.21M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$1.87M 10-Q · filed 2019-06-21 |